ELVN Enliven Therapeutics, Inc. - Common Stock
$60.13
价格 · 八月 18, 2026
截至...的财报数据 八月 5, 2026
52周区间
$15–$62
95% of range
分析师评级
BUY
18 analysts
目标价
$72
+20% upside
P/E (TTM)
-32.9
ROE
-21.9%
净利润率
—
ELVN 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$60.13
市值
$3.57B
P/E (TTM)
-32.9
每股收益 (TTM)
$-1.83
营收 (TTM)
—
股息收益率
—
ROE
-21.9%
负债/权益
—
52周区间
$15 – $62
ELVN 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
—
EPS
$-1.83
2021-12-31
→
2025-12-31
自由现金流
$-70M
2020-12-31
→
2025-12-31
利润率
—
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
ELVN
同行中位数
P/E (TTM)
-32.9
38.7
P/B (市净率)
7.8
3.8
Price / FCF (股价/自由现金流)
-50.7
—
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
ELVN
同行中位数
ROA
-25.9%
-6.4%
ROE
-21.9%
-16.8%
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
ELVN
同行中位数
Current Ratio (流动比率)
28.7
12.8
Quick Ratio (速动比率)
27.9
—
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
ELVN
同行中位数
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
ELVN
同行中位数
ELVN 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
18 位分析师
- 强烈买入 7 38.9%
- 买入 10 55.6%
- 持有 1 5.6%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
9 位分析师 · 2026-08-17
中位数
$70.00
平均值
$72.22
← 低于所有目标
$60.13
最低
$62.00
最高
$82.00
中位数目标
$70.00
+16.4%
平均目标
$72.22
+20.1%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
0.01%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年6月30日 | $-0.49 | $-0.41 | -0.08% |
| 2026年3月31日 | $-0.38 | $-0.47 | 0.09% |
| 2025年12月31日 | $-0.48 | $-0.39 | -0.09% |
| 2025年9月30日 | $-0.32 | $-0.44 | 0.12% |
| 2025年6月30日 | $-0.49 | $-0.54 | 0.05% |
| 2025年3月31日 | $-0.57 | $-0.51 | -0.06% |
同行比较（GICS 子行业） 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| ELVN | $915M | -8.4 | — | — | -21.9% | — |
| AMRX | — | 57.3 | 8.1% | 2.4% | -80.0% | 36.9% |
| LGND | $3.74B | 30.8 | 60.4% | 46.4% | 13.5% | — |
| EWTX | $2.64B | -15.2 | — | — | -30.2% | — |
| INDV | — | 21.9 | 4.3% | 17.0% | -118.3% | 80.2% |
| MANE | — | — | — | — | 82.6% | — |
| GPCR | $14.78B | -86.9 | — | — | -12.3% | — |
| OGN | $1.87B | 10.0 | -2.9% | 3.0% | 25.2% | 53.3% |
| MBX | $1.42B | -13.3 | — | — | -29.6% | — |
| ALMS | — | -3.4 | — | -1011.8% | -61.9% | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 13
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| R&D Expense | $86M | $81M | $65M | $31M | $38M | $32M | $19M | |
| SG&A Expense | $34M | $24M | $19M | $8M | $13M | $10M | $5M | |
| Operating Expenses | $120M | $105M | $84M | $39M | $51M | $42M | $24M | |
| Operating Income | $-120M | $-105M | $-84M | $-39M | $-51M | $-42M | $-24M | |
| Other Non-op | $-49.0K | $-2.0K | $-22.0K | $0 | $-175.0K | $-145.0K | $75.0K | |
| Pretax Income | · | · | · | $2M | $-51M | · | · | |
| Income Tax | $0 | $232.0K | $0 | $0 | · | · | · | |
| Net Income | $-104M | $-89M | $-72M | $-38M | $-51M | $-41M | $-23M | |
| EPS (Basic) | $-1.83 | $-1.89 | $-2.01 | $-12.05 | $-2.37 | · | · | |
| EPS (Diluted) | $-1.83 | $-1.89 | $-2.01 | $-12.05 | $-2.37 | · | · | |
| Shares (Basic) | 56,664,226 | 47,072,532 | 35,546,215 | 3,124,274 | 21,661,450 | · | · | |
| Shares (Diluted) | 56,664,226 | 47,072,532 | 35,546,215 | 3,124,274 | 21,661,450 | · | · | |
| EBITDA | $-119M | $-104M | $-83M | $730.0K | $-51M | $-42M | · |
资产负债表 22
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $99M | $124M | $100M | $76M | $48M | $48M | $5M | |
| Short-term Investments | $364M | $189M | $153M | $0 | · | · | · | |
| Prepaid Expense | $12M | $5M | $3M | $2M | $2M | $2M | $2M | |
| Current Assets | $475M | $318M | $266M | $78M | $93M | $90M | $31M | |
| PP&E (Net) | $34.0K | $458.0K | $742.0K | $890.0K | $250.0K | $349.0K | $442.0K | |
| PP&E (Gross) | $263.0K | $1M | $1M | $1M | $479.0K | $479.0K | $475.0K | |
| Accum. Depreciation | $229.0K | $919.0K | $671.0K | $374.0K | $229.0K | $130.0K | $33.0K | |
| Other Non-current Assets | $656.0K | $7M | $4M | $0 | $175.0K | $88.0K | $2M | |
| Total Assets | $476M | $326M | $272M | $83M | $94M | $91M | $33M | |
| Accounts Payable | $2M | $1M | $532.0K | $3M | $2M | $2M | $2M | |
| Accrued Liabilities | · | · | · | $2M | $5M | $4M | $3M | |
| Current Liabilities | $17M | $16M | $26M | $10M | $7M | $6M | $4M | |
| Capital Leases | $0 | · | $0 | · | $406.0K | · | · | |
| Other Non-current Liabilities | $0 | $0 | $67.0K | $659.0K | · | · | · | |
| Total Liabilities | $17M | $16M | $26M | $10M | $8M | $6M | $4M | |
| Common Stock | $59.0K | $49.0K | $41.0K | $1.0K | $27.0K | $18.0K | $1.0K | |
| Paid-in Capital | $806M | $553M | $400M | $6M | $234M | $181M | $6M | |
| Retained Earnings | $-347M | $-243M | $-154M | $-83M | $-147M | $-96M | $-55M | |
| AOCI | $334.0K | $55.0K | $141.0K | $0 | $-16.0K | $4.0K | $32.0K | |
| Stockholders' Equity | $460M | $310M | $246M | $-77M | $-43M | $84M | $-49M | |
| Liabilities + Equity | $476M | $326M | $272M | $83M | $94M | $91M | $33M | |
| Shares Outstanding | 59,440,045 | 48,936,459 | 41,292,027 | 3,570,019 | 26,287,264 | 17,548,263 | 702,510 |
现金流 11
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $300.0K | $300.0K | $300.0K | $200.0K | · | · | · | |
| Stock-based Comp | $34M | $20M | $13M | $3M | $4M | $2M | $899.0K | |
| Other Non-cash | $-926.0K | $-5M | $-3M | · | · | · | · | |
| Operating Cash Flow | $-70M | $-73M | $-61M | $-32M | $-47M | $-37M | $-22M | |
| CapEx | $158.0K | $44.0K | $149.0K | $612.0K | $12.0K | $18.0K | $140.0K | |
| Investing Cash Flow | $-174M | $-36M | $-148M | $-612.0K | $-2M | $-17M | $-24M | |
| Stock Issued | · | $0 | $161M | $0 | · | · | · | |
| Net Stock Activity | · | $0 | $161M | · | · | · | · | |
| Financing Cash Flow | $219M | $133M | $234M | $-2M | $49M | $97M | $44M | |
| Taxes Paid | $0 | $209.0K | · | · | · | · | · | |
| Free Cash Flow | $-70M | $-73M | $-61M | $-36M | $-47M | $-37M | · |
盈利能力 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| ROA | -25.9% | -29.8% | -40.3% | 1.6% | -55.7% | -66.6% | · | |
| ROE | -21.9% | -29.8% | -28.2% | 13.5% | -55.4% | -46.2% | · | |
| ROIC | · | · | · | 0.76% | · | · | · |
流动性与偿付能力 2
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 28.7 | 20.0 | 10.3 | 49.0 | 12.9 | 14.5 | · | |
| Quick Ratio | 27.9 | 19.7 | 9.8 | 48.2 | 6.7 | 7.6 | · |
估值 (TTM) 8
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-104M | $-89M | $-72M | $-38M | $-51M | $-41M | · | |
| Market Cap | $915M | $1.10B | $571M | $430M | $237M | $1.55B | · | |
| P/E | -8.4 | -11.9 | -6.9 | -1.4 | -3.8 | · | · | |
| P/B | 2.0 | 3.6 | 2.3 | 4.8 | 2.8 | 18.3 | · | |
| P / Tangible Book | 2.0 | 3.6 | 2.3 | · | · | 18.3 | · | |
| P / Cash Flow | -13.0 | -15.0 | -9.3 | -12.1 | -5.1 | -41.4 | · | |
| P / FCF | -13.0 | -15.0 | -9.3 | -12.0 | -5.1 | -41.4 | · | |
| Earnings Yield | -11.9% | -8.4% | -14.5% | -73.7% | -26.3% | · | · |
损益表 12
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $29M | $21M | $21M | $18M | $21M | $25M | $21M | $21M | $19M | $20M | $18M | $20M | $15M | $12M | $8M | $8M | |
| SG&A Expense | $8M | $7M | $13M | $7M | $7M | $7M | $6M | $6M | $6M | $6M | $5M | $5M | $5M | $5M | $2M | $3M | |
| Operating Expenses | $37M | $28M | $34M | $25M | $29M | $32M | $27M | $27M | $25M | $26M | $23M | $24M | $20M | $16M | $10M | $11M | |
| Operating Income | $-37M | $-28M | $-34M | $-25M | $-29M | $-32M | $-27M | $-27M | $-25M | $-26M | $-23M | $-24M | $-20M | $-16M | $-10M | $-11M | |
| Other Non-op | $-8.0K | $0 | $0 | $0 | $-2.0K | $-47.0K | $0 | $0 | $-1.0K | $-1.0K | $-9.0K | $-13.0K | $0 | $0 | $-136.0K | $0 | |
| Income Tax | · | · | $0 | $0 | $0 | · | $0 | $0 | $232.0K | · | $0 | $0 | · | · | · | · | |
| Net Income | $-32M | $-24M | $-30M | $-20M | $-25M | $-29M | $-23M | $-23M | $-20M | $-23M | $-19M | $-21M | $-17M | $-15M | $-10M | $-11M | |
| EPS (Basic) | $-0.49 | $-0.38 | $-0.45 | $-0.32 | $-0.49 | $-0.57 | $-0.46 | $-0.48 | $-0.41 | $-0.54 | $-0.29 | $-0.51 | $-0.41 | $-0.80 | $-2.91 | $-3.27 | |
| EPS (Diluted) | $-0.49 | $-0.38 | $-0.45 | $-0.32 | $-0.49 | $-0.57 | $-0.46 | $-0.48 | $-0.41 | $-0.54 | $-0.29 | $-0.51 | $-0.41 | $-0.80 | $-2.91 | $-3.27 | |
| Shares (Basic) | 66,171,581 | 62,799,326 | -107,585,904 | 62,093,795 | 52,105,052 | 50,051,283 | -91,315,569 | 48,267,458 | 48,075,035 | 42,045,608 | -87,406,707 | 41,030,874 | 40,961,024 | 40,961,024 | -6,085,171 | 3,228,692 | |
| Shares (Diluted) | 66,171,581 | 62,799,326 | -107,585,904 | 62,093,795 | 52,105,052 | 50,051,283 | -91,315,569 | 48,267,458 | 48,075,035 | 42,045,608 | -87,406,707 | 41,030,874 | 40,961,024 | 40,961,024 | -6,085,171 | 3,228,692 | |
| EBITDA | $-37M | $-28M | · | $-25M | $-29M | $-32M | · | $-27M | $-25M | $-26M | · | $-24M | $-20M | $51M | · | $-5M |
资产负债表 22
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $136M | $132M | $99M | $102M | $119M | $102M | $124M | $101M | $97M | $149M | $100M | $74M | $126M | $292M | $76M | $49M | |
| Short-term Investments | $760M | $320M | $364M | $376M | $371M | $188M | $189M | $191M | $216M | $171M | $153M | $190M | $152M | · | $0 | · | |
| Prepaid Expense | $12M | $11M | $12M | $5M | $5M | $5M | $5M | $5M | $6M | $7M | $3M | $5M | $5M | $6M | $2M | $3M | |
| Current Assets | $907M | $463M | $475M | $483M | $496M | $294M | $318M | $297M | $318M | $337M | $266M | $269M | $283M | $298M | $78M | $59M | |
| PP&E (Net) | $140.0K | $20.0K | $34.0K | $399.0K | $462.0K | $404.0K | $458.0K | $549.0K | $630.0K | $683.0K | $742.0K | $806.0K | $867.0K | $853.0K | $890.0K | · | |
| PP&E (Gross) | $390.0K | · | $263.0K | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | · | |
| Accum. Depreciation | $250.0K | $243.0K | $229.0K | $1M | $1M | $993.0K | $919.0K | $908.0K | $828.0K | $750.0K | $671.0K | $593.0K | $515.0K | $441.0K | $374.0K | · | |
| Other Non-current Assets | $1M | $1M | $656.0K | $7M | $7M | $7M | $7M | $7M | $8M | $4M | $4M | $4M | $3M | $3M | $0 | · | |
| Total Assets | $910M | $465M | $476M | $491M | $504M | $303M | $326M | $305M | $327M | $343M | $272M | $274M | $289M | $303M | $83M | $59M | |
| Accounts Payable | $371.0K | $2M | $2M | $1M | $2M | $2M | $1M | $1M | $1M | $3M | $532.0K | $1M | $3M | $6M | $3M | $767.0K | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $1M | |
| Current Liabilities | $14M | $11M | $17M | $15M | $15M | $14M | $16M | $17M | $22M | $25M | $26M | $12M | $9M | $11M | $10M | $2M | |
| Capital Leases | $913.0K | $0 | $0 | $103.0K | $204.0K | $302.0K | · | $0 | $0 | $0 | · | $81.0K | $162.0K | $242.0K | · | · | |
| Other Non-current Liabilities | $913.0K | · | · | $103.0K | $204.0K | $302.0K | · | $0 | $6.0K | $34.0K | $67.0K | $214.0K | $360.0K | $508.0K | $659.0K | · | |
| Total Liabilities | $15M | $11M | $17M | $15M | $15M | $14M | $16M | $17M | $22M | $25M | $26M | $12M | $10M | $11M | $10M | $2M | |
| Common Stock | $73.0K | $61.0K | $59.0K | $59.0K | $59.0K | $49.0K | $49.0K | $47.0K | $47.0K | $47.0K | $41.0K | $41.0K | $41.0K | $41.0K | $1.0K | $27.0K | |
| Paid-in Capital | $1.30B | $824M | $806M | $793M | $786M | $560M | $553M | $508M | $502M | $495M | $400M | $397M | $393M | $389M | $6M | $235M | |
| Retained Earnings | $-403M | $-371M | $-347M | $-317M | $-297M | $-272M | $-243M | $-220M | $-197M | $-177M | $-154M | $-135M | $-114M | $-98M | $-83M | $-178M | |
| AOCI | $-2M | $-382.0K | $334.0K | $221.0K | $-177.0K | $-16.0K | $55.0K | $242.0K | $-139.0K | $-53.0K | $141.0K | $-147.0K | $-111.0K | · | $0 | $-4.0K | |
| Stockholders' Equity | $895M | $453M | $460M | $476M | $488M | $288M | $310M | $288M | $305M | $318M | $246M | $262M | $279M | $291M | $-77M | $57M | |
| Liabilities + Equity | $910M | $465M | $476M | $491M | $504M | $303M | $326M | $305M | $327M | $343M | $272M | $274M | $289M | $303M | $83M | $59M | |
| Shares Outstanding | 73,251,648 | 60,889,655 | 59,440,045 | 59,261,286 | 59,226,171 | 49,038,730 | 48,936,459 | 47,254,280 | 47,173,466 | 46,782,639 | 41,292,027 | 41,204,973 | 41,151,111 | 41,106,277 | 3,570,019 | 26,287,264 |
现金流 11
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $7.0K | $14.0K | $83.0K | $62.0K | $81.0K | $74.0K | $62.0K | $80.0K | $79.0K | $79.0K | $80.0K | $79.0K | $74.0K | $67.0K | $-39M | $60.0K | |
| Stock-based Comp | $14M | $7M | $12M | $7M | $8M | $7M | $5M | $5M | $5M | $5M | $3M | $3M | $4M | $2M | $735.0K | $1M | |
| Other Non-cash | · | $-3M | · | · | · | $-2M | · | · | · | $-5M | · | · | · | $-75M | · | · | |
| Operating Cash Flow | $-19M | $-19M | $-16M | $-13M | $-17M | $-24M | $-17M | $-12M | $-20M | $-23M | $-12M | $-16M | $-12M | $-21M | $-8M | $6M | |
| CapEx | $99.0K | $0 | $0 | $-1.0K | $139.0K | $20.0K | $0 | $22.0K | $2.0K | $20.0K | $14.0K | $16.0K | $88.0K | $31.0K | $101.0K | $169.0K | |
| Investing Cash Flow | $-442M | $43M | $12M | $-4M | $-184M | $1M | $727.0K | $15M | $-34M | $-18M | $39M | $-36M | $-152M | $-31.0K | $-101.0K | $-12M | |
| Stock Issued | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $-2M | $163M | $0 | $0 | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $163M | · | · | |
| Financing Cash Flow | $463M | $10M | $623.0K | $-368.0K | $218M | $234.0K | $40M | $1M | $2M | $90M | $90.0K | $-425.0K | $-3M | $237M | $-2M | $164.0K | |
| Taxes Paid | · | · | $0 | · | · | · | $-23.0K | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | $-19M | · | · | · | $-24M | · | · | · | $-23M | · | · | · | $-21M | · | · |
盈利能力 2
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -4.6% | -6.2% | · | -5.1% | -6.1% | -8.8% | · | -8.0% | -6.5% | -7.0% | · | -12.5% | -9.5% | -7.7% | · | -5.5% | |
| ROE | -4.7% | -6.4% | · | -5.3% | -6.4% | -9.4% | · | -8.4% | -6.8% | -7.5% | · | -13.0% | -9.8% | -8.1% | · | -5.9% |
流动性与偿付能力 2
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 64.1 | 40.3 | · | 32.9 | 32.6 | 21.1 | · | 17.4 | 14.4 | 13.5 | · | 22.2 | 31.0 | 27.2 | · | 32.5 | |
| Quick Ratio | 63.2 | 39.4 | · | 32.6 | 32.2 | 20.7 | · | 17.1 | 14.1 | 12.8 | · | 21.8 | 30.4 | 26.7 | · | 27.2 |
估值 (TTM) 8
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-102M | $-98M | · | $-97M | $-97M | $-94M | · | $-87M | $-80M | $-75M | · | $-63M | $-51M | $-43M | · | $-42M | |
| Market Cap | $3.72B | $2.39B | · | $1.21B | $1.19B | $965M | · | $1.21B | $1.10B | $823M | · | $563M | $840M | $900M | · | $240M | |
| P/E | -30.2 | -22.3 | · | -11.0 | -10.3 | -9.8 | · | -13.2 | -12.5 | -7.8 | · | -2.7 | -2.8 | -2.2 | · | -0.9 | |
| P/B | 4.2 | 5.3 | · | 2.5 | 2.4 | 3.3 | · | 4.2 | 3.6 | 2.6 | · | 2.2 | 3.0 | 3.1 | · | 4.2 | |
| P / Tangible Book | 4.2 | 5.3 | · | 2.5 | 2.4 | 3.3 | · | 4.2 | 3.6 | 2.6 | · | 2.2 | 3.0 | 3.1 | · | 4.2 | |
| P / Cash Flow | · | -123.7 | · | · | · | -40.0 | · | · | · | -35.2 | · | · | · | -43.2 | · | · | |
| P / FCF | · | -123.7 | · | · | · | -40.0 | · | · | · | -35.2 | · | · | · | -43.1 | · | · | |
| Earnings Yield | -3.3% | -4.5% | · | -9.1% | -9.7% | -10.2% | · | -7.6% | -8.0% | -12.8% | · | -36.5% | -36.0% | -45.4% | · | -108.3% |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 净收入 | $-104M | $-89M | $-72M | $-38M | $-51M |
| 稀释后每股收益 (EPS) | $-1.83 | $-1.89 | $-2.01 | $-12.05 | $-2.37 |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 流动比率 | 28.7 | 20.0 | 10.3 | 49.0 | 12.9 |
| 速动比率 | 27.9 | 19.7 | 9.8 | 48.2 | 6.7 |
现金流
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 自由现金流 | $-70M | $-73M | $-61M | $-36M | $-47M |
最新新闻 提及该公司的近期头条新闻
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。
机构持有人 (13F) 221 家申报者 · $3.4B 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 62 (-10 与上一季度对比) | 15 (0 与上一季度对比) | 77 (+19 与上一季度对比) | 51 (+18 与上一季度对比) | +12.8M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| FMR LLC | $449607902 | 8859269 | 13.25% | 股份 |
| ORBIMED ADVISORS LLC | $343914074 | 6776632 | 10.13% | 股份 |
| Polar Capital Holdings Plc | $326354777 | 6430636 | 9.62% | 股份 |
| Vestal Point Capital, LP | $203000000 | 4000000 | 5.98% | 股份 |
| Commodore Capital LP | $166206250 | 3275000 | 4.90% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $130376852 | 2569002 | 3.84% | 股份 |
| CITADEL ADVISORS LLC | $101874840 | 2007386 | 3.00% | 股份 |
| Fairmount Funds Management LLC | $94173933 | 1855644 | 2.78% | 股份 |
| Siren, L.L.C. | $90051358 | 1774411 | 2.65% | 股份 |
| Bellevue Group AG | $75617500 | 1490000 | 2.23% | 股份 |
| First Light Asset Management, LLC | $69058063 | 1360750 | 2.04% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $62098160 | 1223306 | 1.83% | 股份 |
| STATE STREET CORP | $61591012 | 1213616 | 1.82% | 股份 |
| Pictet Asset Management Holding SA | $58960538 | 1161784 | 1.74% | 股份 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $54978135 | 1083313 | 1.62% | 股份 |
| NOVO HOLDINGS A/S | $50750000 | 1000000 | 1.50% | 股份 |
| First Turn Management, LLC | $48433770 | 954360 | 1.43% | 股份 |
| BAKER BROS. ADVISORS LP | $45938443 | 905191 | 1.35% | 股份 |
| Candriam S.C.A. | $45918733 | 905674 | 1.35% | 股份 |
| Tri Locum Partners LP | $43985837 | 866716 | 1.30% | 股份 |
| ALLIANCEBERNSTEIN L.P. | $35129511 | 896161 | 1.04% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $31686828 | 624371 | 0.93% | 股份 |
| Balyasny Asset Management L.P. | $30814842 | 607189 | 0.91% | 股份 |
| AMERICAN CENTURY COMPANIES INC | $28732976 | 566165 | 0.85% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $28560222 | 562763 | 0.84% | 股份 |
| Avidity Partners Management LP | $27912500 | 550000 | 0.82% | 股份 |
| MARSHALL WACE, LLP | $26713227 | 526369 | 0.79% | 股份 |
| Venrock Adviser, LLC | $26711298 | 526331 | 0.79% | 股份 |
| Affinity Asset Advisors, LLC | $25375000 | 500000 | 0.75% | 股份 |
| SILVERARC CAPITAL MANAGEMENT, LLC | $24836137 | 489382 | 0.73% | 股份 |
| Logos Global Management LP | $23598750 | 465000 | 0.70% | 股份 |
| Rock Springs Capital Management LP | $23579719 | 464625 | 0.69% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $21540330 | 424440 | 0.63% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $20876622 | 411362 | 0.62% | 股份 |
| Nicholas Investment Partners, LP | $19870097 | 391529 | 0.59% | 股份 |
| ADAR1 Capital Management, LLC | $19676689 | 387718 | 0.58% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $19462118 | 383490 | 0.57% | 股份 |
| SAMLYN CAPITAL, LLC | $17678966 | 348354 | 0.52% | 股份 |
| Woodline Partners LP | $17617457 | 347142 | 0.52% | 股份 |
| STEMPOINT CAPITAL LP | $17605886 | 346914 | 0.52% | 股份 |
| Spruce Street Capital LP | $16697055 | 329006 | 0.49% | 股份 |
| Longaeva Partners L.P. | $15862420 | 312560 | 0.47% | 股份 |
| JENNISON ASSOCIATES LLC | $15692866 | 309219 | 0.46% | 股份 |
| Assenagon Asset Management S.A. | $15558631 | 306574 | 0.46% | 股份 |
| D. E. Shaw & Co., Inc. | $15514427 | 305703 | 0.46% | 股份 |
| Seven Fleet Capital Management LP | $14673652 | 289136 | 0.43% | 股份 |
| GOLDMAN SACHS GROUP INC | $14142655 | 278673 | 0.42% | 股份 |
| AMERIPRISE FINANCIAL INC | $12518808 | 246676 | 0.37% | 股份 |
| Deep Track Capital, LP | $11418750 | 225000 | 0.34% | 股份 |
| Blackstone Inc. | $10949008 | 215744 | 0.32% | 股份 |
| Patient Square Capital LP | $10784375 | 212500 | 0.32% | 股份 |
| Soleus Capital Management, L.P. | $8408108 | 165677 | 0.25% | 股份 |
| Squadron Capital Management LLC | $8120000 | 160000 | 0.24% | 股份 |
| Connor, Clark & Lunn Investment Management Ltd. | $8044992 | 158522 | 0.24% | 股份 |
| Integral Health Asset Management, LLC | $7612500 | 150000 | 0.22% | 股份 |
| Cormorant Asset Management, LP | $7612500 | 150000 | 0.22% | 股份 |
| NEUBERGER BERMAN GROUP LLC | $7131187 | 140516 | 0.21% | 股份 |
| HighVista Strategies LLC | $6996700 | 137866 | 0.21% | 股份 |
| Eversept Partners, LP | $6934023 | 136631 | 0.20% | 股份 |
| Ikarian Capital, LLC | $6421957 | 126541 | 0.19% | 股份 |
| SPHERA FUNDS MANAGEMENT LTD. | $5722824 | 112765 | 0.17% | 股份 |
| J. Goldman & Co LP | $5690547 | 112129 | 0.17% | 股份 |
| TD Asset Management Inc | $5569204 | 109738 | 0.16% | 股份 |
| Cinctive Capital Management LP | $5465166 | 107688 | 0.16% | 股份 |
| Exome Asset Management LLC | $5085302 | 100203 | 0.15% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $4892300 | 96400 | 0.14% | 买入期权 |
| Swiss National Bank | $4799580 | 94573 | 0.14% | 股份 |
| VANGUARD GROUP INC | $4679767 | 303881 | 0.14% | 股份 |
| BANK OF AMERICA CORP /DE/ | $3977531 | 78375 | 0.12% | 股份 |
| DV EQUITIES, LLC | $3869688 | 76250 | 0.11% | 股份 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $3819699 | 75265 | 0.11% | 股份 |
| Artia Global Partners LP | $3659075 | 72100 | 0.11% | 股份 |
| ALGERT GLOBAL LLC | $3658568 | 72090 | 0.11% | 股份 |
| CITADEL ADVISORS LLC | $3654000 | 72000 | 0.11% | 卖出期权 |
| Informed Momentum Co LLC | $3574424 | 70432 | 0.11% | 股份 |
| SEVEN GRAND MANAGERS, LLC | $3552500 | 70000 | 0.10% | 股份 |
| GREAT POINT PARTNERS LLC | $3552500 | 70000 | 0.10% | 股份 |
| NEW YORK STATE COMMON RETIREMENT FUND | $3407913 | 67151 | 0.10% | 股份 |
| WELLINGTON MANAGEMENT GROUP LLP | $3307581 | 65174 | 0.10% | 股份 |
| BlackRock, Inc. | $3106306 | 61208 | 0.09% | 股份 |
| RHUMBLINE ADVISERS | $2904972 | 57241 | 0.09% | 股份 |
| Schonfeld Strategic Advisors LLC | $2836112 | 55884 | 0.08% | 股份 |
| Atom Investors LP | $2543692 | 50122 | 0.07% | 股份 |
| Caption Management, LLC | $2537500 | 50000 | 0.07% | 买入期权 |
| Jones Hill Capital LP | $2529888 | 49850 | 0.07% | 股份 |
| BNP PARIBAS FINANCIAL MARKETS | $2318514 | 45685 | 0.07% | 股份 |
| TUDOR INVESTMENT CORP ET AL | $2035989 | 40118 | 0.06% | 股份 |
| WELLS FARGO & COMPANY/MN | $1983259 | 39079 | 0.06% | 股份 |
| BOOTHBAY FUND MANAGEMENT, LLC | $1980823 | 39031 | 0.06% | 股份 |
| JANE STREET GROUP, LLC | $1908200 | 37600 | 0.06% | 买入期权 |
| Trexquant Investment LP | $1902668 | 37491 | 0.06% | 股份 |
| Bank of New York Mellon Corp | $1766658 | 34811 | 0.05% | 股份 |
| TimesSquare Capital Management, LLC | $1764000 | 45000 | 0.05% | 股份 |
| VANGUARD ASSET MANAGEMENT, Ltd | $1696674 | 33432 | 0.05% | 股份 |
| Ishara Investments LP | $1664600 | 32800 | 0.05% | 股份 |
| Brevan Howard Capital Management LP | $1660439 | 32718 | 0.05% | 股份 |
| Engineers Gate Manager LP | $1479464 | 29152 | 0.04% | 股份 |
| CITIGROUP INC | $1433180 | 28240 | 0.04% | 股份 |
| Vanguard Global Advisers, LLC | $1361775 | 26833 | 0.04% | 股份 |
| JANE STREET GROUP, LLC | $1344875 | 26500 | 0.04% | 卖出期权 |
公司内部人士 28 位内幕人士 · 7 位高管 · 18 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Samuel Kintz | President and CEO | 2024年1月25日 M | 0 | 0 | 0 | $0 |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | 2026年7月17日 M | 46054 | 0 | 8 | $-580338 |
| Michael Gray | CFO & COO | 2023年2月22日 S | 27610 | 0 | 0 | $0 |
| Anish Patel | Chief Operating Officer | 2024年1月22日 S | 17222 | 0 | 0 | $0 |
| Helen Louise Collins | CHIEF MEDICAL OFFICER | 2026年7月17日 M | 25000 | 0 | 8 | $-482386 |
| Joseph P Lyssikatos | Chief Scientific Officer | 2023年12月29日 M | 0 | 0 | 0 | $0 |
| Kenneth Attie | SVP, CMO | 2022年1月28日 A | 34100 | 0 | 0 | $0 |
| Lori Anne Kunkel | 董事 | 2026年7月6日 S | 41884 | 0 | 3 | $-771524 |
| Rishi Gupta | 董事 | 2024年5月16日 S | 7663349 | 0 | 0 | $0 |
| Richard A. Heyman | 董事 | 2023年12月22日 S | 29216 | 0 | 0 | $0 |
| Andrew John Phillips | 董事 | 2023年2月23日 A | — | 0 | 0 | $0 |
| Rahul D. Ballal | 董事 | 2023年2月23日 A | 87835 | 0 | 0 | $0 |
| Jake Bauer | 董事 | 2023年2月23日 A | 87372 | 0 | 0 | $0 |
| Andrew J. Schwab | 董事 | 2023年2月23日 A | 960383 | 0 | 0 | $0 |
| Laura A Williams | 董事 | 2022年6月2日 A | — | 0 | 0 | $0 |
| Mark Chin | 董事 | 2022年6月2日 A | 2344072 | 0 | 0 | $0 |
| Edward R. Conner | 董事 | 2022年6月2日 A | — | 0 | 0 | $0 |
| Barbara Dalton | 董事 | 2022年6月2日 A | 1557722 | 0 | 0 | $0 |
| David P Bonita | 董事 | 2022年6月2日 A | 4199068 | 0 | 0 | $0 |
| David M Mott | 董事 | 2022年6月2日 A | 229224 | 0 | 0 | $0 |
| Carl Goldfischer | 董事 | 2022年6月2日 A | — | 0 | 0 | $0 |
| James G Mcarthur | 董事 | 2020年3月16日 A | — | 0 | 0 | $0 |
| Mette Kirstine Agger | 董事 | 2020年3月16日 A | 1432722 | 0 | 0 | $0 |
| Alexandria Venture Investments, LLC | 10% 所有者 | 2020年3月16日 C | 293013 | 0 | 0 | $0 |
| Lundbeckfond Invest A/S | 10% 所有者 | 2020年3月16日 C | 1432722 | 0 | 0 | $0 |
| H LUNDBECK A S | 10% 所有者 | 2020年3月16日 C | 522499 | 0 | 0 | $0 |
| Mika K Derynck | — | 2026年8月4日 M | 0 | 0 | 1 | $-9561047 |
| Sara M. Nayeem | — | 2021年6月29日 A | — | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
激进投资者及 5%+ 股东 7 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC, ORBIMED CAPITAL GP VII LLC, ORBIMED GENESIS GP LLC, ORBIMED CAPITAL LLC ×7 申报 | 2026年6月24日 | 9.50% | 修订 | — | SEC |
| 5AM Ventures VI, L.P., 5AM Partners VI, LLC, 5AM Opportunities I, L.P., 5AM Opportunities I (GP), LLC, Kush Parmar, Andrew J. Schwab ×5 申报 | 2024年7月29日 | — | 初始申报 | — | SEC |
| 5AM Partners VI, LLC, 5AM Opportunities I, L.P., 5AM Opportunities I (GP), LLC, Kush Parmar, Andrew J. Schwab | 2023年3月6日 | — | 初始申报 | 被动投资 | SEC |
| 2022年5月24日 | — | 初始申报 | — | SEC | |
| New Enterprise Associates 14, L.P., NEA Partners 14, L.P., NEA 14 GP, LTD, Forest Baskett, Anthony A. Florence, Jr., Patrick J. Kerins, Scott D. Sandell, Peter W. Sonsini ×3 申报 | 2022年4月25日 | — | 初始申报 | 被动投资 | SEC |
| Arix Bioscience Plc, Arix Bioscience Holdings Limited, Mark Chin ×3 申报 | 2021年7月20日 | — | 初始申报 | — | SEC |
| Arix Bioscience Plc (2), Arix Bioscience Holdings Limited (2), Mark Chin (1) (2) | 2020年3月24日 | — | 初始申报 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 48 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 1.81% | 16370 NS | 2026年4月30日 | N-PORT |
| PTH · Invesco Exchange-Traded Fund Trust | 1.80% | 73604 SH | 2026年8月8日 | 每日 |
| PILL · Direxion Shares ETF Trust | 1.80% | 5620 NS | 2026年4月30日 | N-PORT |
| CANC · Tema ETF Trust | 1.31% | 58197 NS | 2026年5月31日 | N-PORT |
| FMED · Fidelity Covington Trust | 1.03% | 10703 NS | 2026年5月31日 | N-PORT |
| IHE · iShares Trust | 0.72% | 194624 SH | 2026年8月8日 | 每日 |
| DWAS · Invesco Exchange-Traded Fund Trus... | 0.51% | 38057 SH | 2026年8月8日 | 每日 |
| IBB · iShares Trust | 0.26% | 407872 SH | 2026年8月8日 | 每日 |
| IBBQ · Invesco Exchange-Traded Fund Trus... | 0.25% | 3315 SH | 2026年8月8日 | 每日 |
| ESSC · Strategy Shares | 0.23% | 1424 NS | 2026年4月30日 | N-PORT |
| FFSM · FIDELITY COVINGTON TRUST | 0.16% | 51358 NS | 2026年4月30日 | N-PORT |
| IWO · iShares Trust | 0.16% | 388661 SH | 2026年8月8日 | 每日 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.13% | 45928 SH | 2026年8月8日 | 每日 |
| VFMO · VANGUARD WELLINGTON FUND | 0.12% | 47349 SH | 2026年8月8日 | 每日 |
| BIB · ProShares Trust | 0.12% | 2196 NS | 2026年5月31日 | N-PORT |
| NUSC · Nushares ETF Trust | 0.11% | 34350 NS | 2026年4月30日 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0.09% | 61669 NS | 2026年5月31日 | N-PORT |
| IWM · iShares Trust | 0.08% | 1094617 SH | 2026年8月8日 | 每日 |
| ISCG · iShares Trust | 0.07% | 12024 SH | 2026年8月8日 | 每日 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.07% | 246533 SH | 2026年8月8日 | 每日 |
| ESML · iShares Trust | 0.07% | 33580 SH | 2026年8月8日 | 每日 |
| ISCB · iShares Trust | 0.05% | 2494 SH | 2026年8月8日 | 每日 |
| DFAS · Dimensional ETF Trust | 0.05% | 175955 NS | 2026年4月30日 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0.04% | 141971 SH | 2026年8月8日 | 每日 |
| ITWO · ProShares Trust | 0.04% | 1852 NS | 2026年5月31日 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0.04% | 214005 NS | 2026年5月31日 | N-PORT |
| ISCV · iShares Trust | 0.03% | 3976 SH | 2026年8月8日 | 每日 |
| VXF · VANGUARD INDEX FUNDS | 0.03% | 624513 SH | 2026年8月8日 | 每日 |
| WSML · iShares Trust | 0.03% | 2892 SH | 2026年8月8日 | 每日 |
| UWM · ProShares Trust | 0.02% | 1449 NS | 2026年5月31日 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.02% | 14804 NS | 2026年4月30日 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.02% | 8632 SH | 2026年8月8日 | 每日 |
| URTY · ProShares Trust | 0.02% | 1465 NS | 2026年5月31日 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.01% | 1649 NS | 2026年5月31日 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0.01% | 22815 NS | 2026年5月31日 | N-PORT |
| HDG · ProShares Trust | 0.01% | 37 NS | 2026年5月31日 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.01% | 4666 NS | 2026年4月30日 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.01% | 569 NS | 2026年4月30日 | N-PORT |
| ITOT · iShares Trust | 0.00% | 66943 SH | 2026年8月8日 | 每日 |
| IWV · iShares Trust | 0.00% | 12036 SH | 2026年8月8日 | 每日 |
| DFUS · Dimensional ETF Trust | 0.00% | 14379 NS | 2026年4月30日 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 7755 NS | 2026年4月30日 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0.00% | 30821 NS | 2026年5月31日 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 28939 NS | 2026年4月30日 | N-PORT |
| TILT · FlexShares Trust | 0.00% | 154 NS | 2026年4月30日 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0.00% | 691 NS | 2026年5月31日 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 1883832 SH | 2026年8月8日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 3533 SH | 2026年8月8日 | 每日 |